Chemistry:Simmerafil
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | TPN171 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C24H35N5O3 |
| Molar mass | 441.576 g·mol−1 |
Simmerafil[1] (TPN171H) is a selective PDE5 inhibitor[2] in development for the treatment of erectile dysfunction[3] and pulmonary hypertension.[4]
References
- ↑ Odilov, Abdullajon; Liu, Yin; Hu, Tianwen; Jiang, Xiangrui; Suo, Jin; Tian, Guanghui; Yang, Feipu; Shen, Jingshan (19 November 2021). "Facile and Cost-Effective Route for the Synthesis of Simmerafil" (in en). Organic Process Research & Development 25 (11): 2432–2437. doi:10.1021/acs.oprd.1c00184. ISSN 1083-6160. https://pubs.acs.org/doi/full/10.1021/acs.oprd.1c00184.
- ↑ Qian, Hongjie; Chen, Qian; Liang, Liyu; Zou, Yang; Pu, Huahua; Xin, Liang; Song, Rong; Li, Tingting et al. (2021). "A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects". Drug Design, Development and Therapy 15: 2947–2959. doi:10.2147/DDDT.S308610. ISSN 1177-8881. PMID 34262260.
- ↑ "Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction". CTG Labs. https://www.clinicaltrials.gov/study/NCT05188989.
- ↑ Zhao, Congke; Hu, Liqing; He, Xiangrong; Li, Lijun; Yin, Minghui; Tettey, Abraham Terkpertey; Wang, Yu; Shen, Jingshan et al. (1 August 2022). "TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats". Vascular Pharmacology 145: 107017. doi:10.1016/j.vph.2022.107017. ISSN 1537-1891. PMID 35680060. https://www.sciencedirect.com/science/article/abs/pii/S1537189122000660.
 |  |
